文献速递流行病学与生物统计医学教育与科研方法

COS-Speech:制定卒中后构音障碍核心结局指标集用于临床实践与研究的方案

COS-Speech: protocol to develop a core outcome set for dysarthria after stroke for use in clinical practice and research.
PubMed 文献 · Trials · 2023-01-25

卒中后构音障碍影响半数卒中幸存者,目前临床研究使用的结局指标各异,导致结果无法比较。COS-Speech研究拟通过五个步骤制定核心结局指标集(COS),包括构建结局域长列表、招募英国和澳大利亚的卒中幸存者、沟通研究人员及言语治疗师三组利益相关者、开展两轮德尔菲调查、召开共识会议并匹配现有测量工具,最终形成可在所有构音障碍研究和临床实践中使用的最小核心结局指标集。

要点

  • 卒中后构音障碍发生于半数卒中幸存者,可导致社交隔离和心理健康不良。
  • 目前临床研究使用的结局指标各异,使试验结果无法比较,阻碍有效治疗的理解。
  • COS-Speech将通过五步法制定核心结局指标集,供研究和临床实践使用。

核心结论

  • 目前尚无针对卒中后构音障碍的核心结局指标集(COS),COS-Speech将制定一个适用于所有构音障碍研究和临床实践的最小核心结局指标集。

研究设计与样本

  • COS-Speech研究包括五个步骤:第一步开发可能应测量的言语结局域长列表以指导调查;第二步在英国和澳大利亚招募卒中幸存者、沟通研究人员及言语治疗师/言语病理学家三个关键利益相关者群体;第三步开展两轮德尔菲调查;第四步召开共识会议确定应测量的言语结局,并召开后续共识会议将现有工具/测量(来自平行系统综述)匹配至商定的COS-Speech;第五步传播COS-Speech。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Dysarthria after stroke is when speech intelligibility is impaired, and this occurs in half of all stroke survivors. Dysarthria often leads to social isolation, poor psychological well-being and can prevent return to work and social lives. Currently, a variety of outcome measures are used in clinical research and practice when monitoring recovery for people who have dysarthria. When research studies use different measures, it is impossible to compare results from trials and delays our understanding of effective clinical treatments. The aim of this study is to develop a core outcome set (COS) to agree what aspects of speech recovery should be measured for dysarthria after stroke (COS-Speech) in research and clinical practice. METHODS: The COS-Speech study will include five steps: (1) development of a long list of possible outcome domains of speech that should be measured to guide the survey; (2) recruitment to the COS-Speech study of three key stakeholder groups in the UK and Australia: stroke survivors, communication researchers and speech and language therapists/pathologists; (3) two rounds of the Delphi survey process; (4) a consensus meeting to agree the speech outcomes to be measured and a follow-up consensus meeting to match existing instruments/measures (from parallel systematic review) to the agreed COS-Speech; (5) dissemination of COS-Speech. DISCUSSION: There is currently no COS for dysarthria after stroke for research trials or clinical practice. The findings from this research study will be a minimum COS, for use in all dysarthria research studies and clinical practice looking at post-stroke recovery of speech. These findings will be widely disseminated using professional and patient networks, research and clinical forums as well as using a variety of academic papers, videos, accessible writing such as blogs and links on social media. TRIAL REGISTRATION: COS-Speech is registered with the Core Outcome Measures in Effectiveness Trials (COMET) database, October 2021 https://www.comet-initiative.org/Studies/Details/1959 . In addition, "A systematic review of the psychometric properties and clinical utility of instruments measuring dysarthria after stroke" will inform the consensus meeting to match measures to COS-Speech. The protocol for the systematic reviews registered with the International Prospective Register of Systematic Reviews. PROSPERO registration number: CRD42022302998 .

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Mitchell C, Bowen A, Conroy P, et al. COS-Speech: protocol to develop a core outcome set for dysarthria after stroke for use in clinical practice and research. Trials. 2023. PMID: 36698201. doi:10.1186/s13063-022-06958-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。